ハイパルトロフィーの人の心臓における信号伝達経路の微分活性化と,進行した心不全の対比
1Cardiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Circulation
|February 7, 2001
まとめ
心不全時の心臓のシグナル伝達経路のシフト. ハイパルトロフィーはカルシヌーリンの優位性を示すが,心不全はミトゲン活性化タンパク質キナーゼ (MAPKs) とAkt/グリコゲン合成キナーゼ-3 (GSK-3) を活性化させ,潜在的に心不全の進行に影響を与える.
科学分野:
- 心血管生物学 心血管生物学
- 分子心臓病学 分子心臓病学
- 細胞シグナル伝達 細胞信号伝達
背景:
- 左心室不全はしばしば心筋縮に続く.
- MAPK,Akt/GSK-3,カルシヌーリンのようなシグナル伝達経路は,縮とアポトーシスの両方に関与しています.
- これらの経路を理解することは,心不全のメカニズムにとって極めて重要です.
研究 の 目的:
- ヒトの心不全および心縮における重要なシグナル伝達経路の活動を調査する.
- 補償性高縮症と進行性心不全の間のシグナル伝達プロフィールを比較する.
主な方法:
- 進行性心不全,補償性心筋縮,および正常な被験者からの心臓組織におけるシグナル伝達経路活動の分析.
- ミトゲン活性化タンパク質キナーゼ (MAPKs),Akt,グリコゲン合成キナーゼ-3 (GSK-3),およびカルシヌーリンの評価された活性.
主要な成果:
- ハイパルトロフィーでは,カルシヌーリンは支配的な活性化経路であったが,MAPKsとAkt/GSK-3は活性化されなかった.
- 衰弱した心臓ではカルシヌーリンの活性が増加したが,MAPKsとAktは活性化され,GSK-3の抑制につながった.
- これらの経路の活性化は,心筋病の原因 (イシュケミックまたはイディオパシー) にかかわらず発生しました.
結論:
- 心不全は,おそらくストレスや神経ホルモン要因による,プロハイパートロフィックなシグナル伝達プロファイルを示します.
- ハイパートロフィック経路の活性化により,プロアポプトティック信号とアンチアポプトティック信号の両方が生成されます.
- これらのシグナル伝達経路を調節することで,心不全の進行に対する潜在的な治療戦略が提供されます.
関連する概念動画
01:17Pathophysiology of Heart Failure
4.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K
01:27Heart Failure I: Introduction
1.4K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.4K
01:29Heart Failure II: Pathophysiology
1.6K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
836
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
836
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
801
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
01:26Cellular Adaptation II: Hypertrophy
37
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
37